Volume 5, Issue 5 pp. 365-369

Unusual evolution of an Epstein–Barr
virus-associated leiomyosarcoma occurring after liver transplantation

Bénédicte Brichard

Bénédicte Brichard

Departments of Pediatric Hematology and Oncology,

Search for more papers by this author
Françoise Smets

Françoise Smets

Pediatrics,

Search for more papers by this author
Etienne Sokal

Etienne Sokal

Pediatrics,

Search for more papers by this author
Philippe Clapuyt

Philippe Clapuyt

Pediatric Radiology,

Search for more papers by this author
Christiane Vermylen

Christiane Vermylen

Departments of Pediatric Hematology and Oncology,

Search for more papers by this author
Guy Cornu

Guy Cornu

Departments of Pediatric Hematology and Oncology,

Search for more papers by this author
Jacques Rahier

Jacques Rahier

Pathology,

Search for more papers by this author
Jean Bernard Otte

Jean Bernard Otte

Pediatric Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, 1200 Brussels, Belgium

Search for more papers by this author
First published: 21 December 2001
Citations: 64
Bénédicte Brichard, MD, PhD, Department of Pediatric Hematology and Oncology, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium
Tel.: 32-2-7642550
Fax: 32-2-7648964
E-mail: [email protected]

Abstract

Abstract: We report the case of a child who developed, 2 yr after orthotopic liver transplantation (OLTx) for biliary atresia, a multi-focal hepatic tumor with lymphonodular metastases, identified as an Epstein–Barr virus (EBV)-associated leiomyosarcoma. Chemotherapy was given without tumor response. Subsequently, slow growth of the tumor was observed. Immunosuppression was tapered and stopped 9 yr after transplantation. At the present time, 12 yr after the discovery of the first hepatic lesions, the patient is alive and completely symptom-free, the abdominal masses are stable, and liver function tests are completely normal. Smooth muscle tumors are increasingly recognized in children with various immunodeficiencies occurring after organ transplantation. This unusual evolution of a clinically aggressive tumor into a stable disease after restoration of immunity confirms that the immune status of the patient is a crucial factor.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.